For prescribers

GLP-1 receptor agonists, NAION, and co-management with eye care

Reviewed by James Deom, OD, MPH, FAAO, Chief of Eye Care Services. Last reviewed: November 11, 2026.

These pages are for primary care, endocrinology, obesity medicine, and other clinicians who prescribe GLP-1 receptor agonists.

• GLP-1 RAs and NAION: what prescribers should know — evidence through November 2026, professional-group positions, a suggested approach, and when to refer.
• When to refer — a one-page urgency guide and contact numbers.

Pages on papilledema/IIH and diabetic retinopathy early worsening are still to be written. Retinopathy monitoring is already summarized on the main prescriber page.

Same-day evaluation and referrals

Providers can call or text Dr. Deom’s cell at 570-436-1930 for a same-day evaluation.

General contact and referrals: Hazleton Eye Specialists, phone 570-453-2020, fax 570-453-1020.

All five offices have OCT, OCT angiography, and fundus photography with autofluorescence, and offer priority scheduling for a baseline or follow-up exam with this imaging set. Office addresses are on Find an Eye Doctor.

Medical disclaimer. This page is educational and is intended for licensed health care professionals. It is not a clinical practice guideline and does not replace clinical judgment, product labeling, or specialty consultation. Information is current as of the “last reviewed” date.